Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Journey through Pages: A Survey of \Plunging into Scholarly Universes\ - 2The Main 15 Powerful Business Heads of Today
- 3Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
- 4Viable Correspondence: Building Solid Connections
- 5Eleven Creations And Developments That Steered History
- 6 Fledgling Cameras for 2024: Ideal for New Photographic artists
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- 75% of US adults may meet criteria for obesity under new definition, study finds
- Audits of 6 American Busssiness Class Flights
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- Vote in favor of the wide open action that revives your brain and soul!
- Influencers are selling a delusional fantasy of being postpartum. Why is it so easy to believe?
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Brilliant and Gleaming: Excellence and Skincare Practices
